Pluriomics uses human stem-cell technology to increase efficiency of drug discovery

Current late-stage attrition models are not predictive enough for selection of safe and effective drug candidates. To prevent issues, a lot of work is required late in the clinical development stage. Because of this, Pluriomics wants to use human stem-cell technology in biopharmaceutical research and development. Human stem-cell technology could increase the efficiency of drug